Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

Hormones and genetics affect hair growth and patterns, with some changes reversible and others not.

The main causes of hirsutism in Jordanian women are PCOS and idiopathic hirsutism.

A girl inherited excessive body hair from her mother and grandmother.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Hirsutism is mainly caused by high androgen levels or sensitivity, with PCOS being the most common cause.

Hirsutism is often caused by high male hormone levels and can be treated with lifestyle changes and medications.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Steroid hormones are crucial for body functions and have various medical uses, but their misuse can lead to dependence.

Dutasteride 0.5mg improves hair growth in 78% of people with hair loss, but may cause sexual problems in some.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

Women with polycystic ovary syndrome (PCOS) show higher levels of hope, judgement, perspective, and transcendence, and could benefit from positive psychology therapy.

PCOS lowers quality of life, causing issues like obesity, infertility, and menstrual problems.

The document concludes that management strategies for PCOS are important due to its common occurrence and associated health risks.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Anorexia Nervosa and Bulimia Nervosa are complex eating disorders with increasing incidence among young females, significant morbidity, and varying mortality rates, requiring more research for better treatment.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

Metformin improves quality of life, emotional health, and sex life in women with polycystic ovary syndrome.

Dianabol boosts muscle growth but has serious health risks and legal issues.

Spironolactone helps reduce hair growth in women with hirsutism but may cause menstrual irregularities.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

As women age, they experience changes in hair density and volume, face challenges in distinguishing normal hair loss from disease, and have limited access to treatments for hair issues.